Dual-functional transdermal drug delivery system with controllable drug loading based on thermosensitive poloxamer hydrogel for atopic dermatitis treatment

Wenyi Wang, Elaine Wat, Chi Leung Hui, Ben Chan, Frency S.F. Ng, Chi Wai Kan, Xiaowen Wang, Huawen Hu, Eric C.W. Wong, Clara B.S. Lau, Ping Chung Leung

Research output: Journal article publicationJournal articleAcademic researchpeer-review

70 Citations (Scopus)


The treatment of atopic dermatitis (AD) has long been viewed as a problematic issue by the medical profession. Although a wide variety of complementary therapies have been introduced, they fail to combine the skin moisturizing and drug supply for AD patients. This study reports the development of a thermo-sensitive Poloxamer 407/Carboxymethyl cellulose sodium (P407/CMCs) composite hydrogel formulation with twin functions of moisture and drug supply for AD treatment. It was found that the presence of CMCs can appreciably improve the physical properties of P407 hydrogel, which makes it more suitable for tailored drug loading. The fabricated P407/CMCs composite hydrogel was also characterized in terms of surface morphology by field emission scanning electron microscopy (FE-SEM), rheological properties by a rheometer, release profile in vitro by dialysis method and cytotoxicity test. More importantly, the findings from transdermal drug delivery behavior revealed that P407/CMCs showed desirable percutaneous performance. Additionally, analysis of cytotoxicity test suggested that P407/CMCs composite hydrogel is a high-security therapy for clinical trials and thus exhibits a promising way to treat AD with skin moisturizing and medication.
Original languageEnglish
Article number24112
JournalScientific Reports
Publication statusPublished - 19 Apr 2016

ASJC Scopus subject areas

  • General

Cite this